The IFB is a Mixed Service Unit, under the supervision of five national research bodies:
In order to achieve the desired impact results, the IFB has reviewed its governance and governing structure. The organization’s operation relies on a continuous interaction with the supervisory authorities (i.e. supervisory committee), the other national ‘omics’ infrastructures and the major national plans. It separates the scientific strategy and the management of operational tasks.
The Executive Board
The IFB Executive Board (CoDir) is composed of the IFB Director, the Deputy Director and three other IFB members; this organisation allows the management of all projects and proposes scientific orientations. Candidate members are submitted by the IFB Directors, then appointed by the Executive Board for a period of three years. The meetings of this directorate take place every fortnight. The directorate is assisted by the IFB governing body, which is made up of four committees in charge of scientific strategy policy and three operational units in charge of managing actions.
The Governing Council
The IFB Governing Council is a subordinate of the IBISA Executive Board, restricted to our 5 "guardianships". This structure has no direct link with the PIA, and will therefore be maintained as a major governing structure. It must however be expanded to reflect the evolution of our partner institutions.
So far, the Executive Board has been restricted to research organisations (CNRS, Inserm, INRAe, CEA, INRIA), while 24 of our platforms are affiliated to universities, of which 7 have a university as their majority affiliation.
The Committee in charge of Strategy and Scientific Orientation (CCSO)
The Committee in charge of Strategy and Scientific Orientation (CCSO), made up of scientific representatives from the various supervisory authorities, a representative of the Ministry, the heads of national infrastructures and national scientific programmes (e.g. France Médecine Génomique Plan 2025).
Concerning the national infrastructures France Génomique, ProFi, MetaboHUB, Frisbi, France BioImaging, France Life Imaging, Biobanks, EMBRC-FR and Constance are the first concerned. This committee defines the main strategic orientations with regard to the report of the Scientific Advisory Board and the associated required budgets. The CCSO interacts regularly with the heads of the operational units, supervises the various actions and discusses new orientations as often as possible. This committee must be set up and will meet at least once a month.
The Ethics Committee
The Ethics Committee assists the IFB Directorate on legislative, ethical and societal issues relating to the fulfilment of all activities in the IFB's missions (e.g. protection of sensitive data, ethical issues related to personal genomics, etc.). It will be made up of scientists and deontologists. Its activities will include the evaluation of ethical issues, the organisation of intra-IFB and public debates as well as communication on ethical issues.
The Industrial Advisory Committee
The former Regulation and Quality Control Unit (CRCQ) is abolished. The implementation of the system quality management (ISO9001/NF X50-900), is currently carried out by a working group that defines and monitors performance indicators. This cell is currently composed of two directors, 5 pilots of the defined process, and Marie-Pierre Dubrulle. In addition, the IFB no longer wishes to undergo the complex process of obtaining the Health Data Hosting Agreement (Accord d'Hébergement de Données Médicales) in accordance with French legislation, as this aspect in particular will be handled by the Inserm's IT Services Department.
Instead of transferring the data to our IT services, we develop strategies to move the software environment upstream of the data, in collaboration with the relevant actors (SSI Inserm). This strategy also corresponds to current trends in international data sharing. (e.g. ELIXIR's investment in the European 1 million genomes project).
The Valorisation and Communication Unit
The Valorisation and Communication unit has been added. It will be made up of representatives of the Valorisation Services of each IFB supervisory authority (at least 5 people), the IFB directors, the coordinators of action A3.2 (links with the industry) and the person in charge of communicating the IFB's actions and results. The recommendations of the Industrial Advisory Committee will be used by this unit in order to prioritise actions dedicated to the valorisation of the IFB's services.
Directors of the IFB : Claudine Medigue & Jacques van Helden
Representatives of the regional centres:
Permanent guests :
Find all the minutes of meetings on the IFB Wiki. This Renater space is accessible, via institutional logins, to all platform members and people interested in our activities and who are referenced in the IFB mailing list. To request your addition to this list, contact us.
Other partner-institutions are also linked to the IFB as they are the supervisory structures of some of the platforms that make up the IFB:
The IFB is one of the national support infrastructures for research specialized in Biology and Health (INBS - National Infrastructure in Biology and Health). The INBSs have strong mutual interactions strengthened by the IFB being at the crossroads of the flows of data of different types, all widespread in bioinformatics research. The major challenge in biology is to integrate data of diverse nature to gain a systemic vision of the organisms studied. The IFB is a major actor in this integration effort; it does by close collaborations with:
WP1. National Distributed Bioinformatics Services Environment
WP2. Innovation: towards integrative bioinformatics
WP3. Links with international networks and industry
WP4. Training and awareness
WP5. Management et governance